Spencer Guthrie

Vice President, Global TTR Strategy at Akcea Therapeutics, Inc.

Spencer Guthrie

Spencer Guthrie

Vice President, Global TTR Strategy at Akcea Therapeutics, Inc.

Overview
RelSci Relationships

150

Birthday

1975

Age

46

Relationships
RelSci Relationships are individuals Spencer Guthrie likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Vice President & Chief Medical Officer at Inozyme Pharma, Inc.

Relationship likelihood: Average

Former Director-Program Management at BioMarin Pharmaceutical, Inc.

Relationship likelihood: Average

Former Senior Director-Clinical Sciences at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Average

Treasurer & Vice President at Dimension Therapeutics, Inc.

Relationship likelihood: Average

Chief Business Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Average

Vice President, Clinical Operations at REGENXBIO, Inc.

Relationship likelihood: Average

Chief Medical Officer at Arrowhead Pharmaceuticals, Inc.

Relationship likelihood: Average

Founder, President & Chief Executive Officer at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Average

Former Vice President, Regulatory Affairs & Quality Assurance at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Average

Chief Technical Operations Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc.

Relationship likelihood: Weak

Paths to Spencer Guthrie
Potential Connections via
Relationship Science
You
Spencer Guthrie
Vice President, Global TTR Strategy at Akcea Therapeutics, Inc.
Education

Vanderbilt University is a center for scholarly research, informed and creative teaching, and service to the community and society at large. Vanderbilt will uphold the highest standards and be a leader in the quest for new knowledge through scholarship, dissemination of knowledge through teaching and outreach, and creative experimentation of ideas and concepts. In pursuit of these goals, Vanderbilt values most highly the intellectual freedom that supports open inquiry and equality, compassion and excellence in all endeavors.

University of California, Irvine is a public research university located in Irvine, California and one of the 10 general campuses in the University of California (UC) system. UCI's Orange County campus is the fifth-largest in the UC system. UC Irvine is considered a Public Ivy and became a member of the Association of American Universities in 1996, and is the youngest university to hold membership. It also administers the UC Irvine Medical Center, a large teaching hospital; the UC Irvine Health Sciences system in the City of Orange; the University of California, Irvine, Arboretum; and a portion of the University of California Natural Reserve System.

Career History
Vice President, Global TTR Strategy
Tenure Unconfirmed

Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.

Senior Director-Clinical Operations
2012 - Prior

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita. Mepsevii is an intravenous, which is used for the treatment of Mucopolysaccharidosis VII. Crysvita is an antibody administered via subcutaneous injection used for the treatment of XLH. The company was founded by Emil D. Kakkis on April 22, 2010 and is headquartered in Novato, CA.

Director-Clinical Operations
Prior
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Spencer Guthrie. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Spencer Guthrie's profile does not indicate a business or promotional relationship of any kind between RelSci and Spencer Guthrie.